Chi-ting Su
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.
Journal: Circulation research
Published: May 26, 2023
Formulation Development of Doxycycline-Loaded Lipid Nanocarriers using Microfluidics by QbD Approach.
Journal: Journal of pharmaceutical sciences
Published: May 20, 2022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 19, 2021
LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.
Journal: Cell death & disease
Published: May 26, 2021
The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation.
Journal: Cell death discovery
Published: November 02, 2018
Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy.
Journal: Current treatment options in cardiovascular medicine
Published: August 28, 2016
A thrifty variant in CREBRF strongly influences body mass index in Samoans.
Journal: Nature genetics
Published: December 07, 2015
Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Journal: Human molecular genetics
Published: December 26, 2014
The role of echocardiographic study in patients with chronic kidney disease.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: September 03, 2014
Last Updated: 09/26/2026